Manufacturing: Page 30
-
FDA plans tougher enforcement of homeopathic medicines
Under a proposed risk-based approach, the regulator would target products claiming to treat serious diseases or that contravene manufacturing standards.
By Suzanne Elvidge • Dec. 20, 2017 -
EMA signs off on Samsung BioLogics manufacturing plant
The Korean drugmaker claims Plant No. 2, as it's known, is the world's single largest biologics plant, with 150,000 liters of production capacity.
By Ned Pagliarulo • Dec. 14, 2017 -
Abzena tapped for preclinical ADC development
The CDMO has entered into an agreement worth more than $5 million with a U.S. biotech.
By Jacob Bell • Dec. 14, 2017 -
FDA warns Korean OTC manufacturer for GMP violations
A recent warning letter from the regulator flagged labeling concerns and lax quality control on the part of the Seoul-based drugmaker.
By Ned Pagliarulo • Dec. 14, 2017 -
Biocad set to begin selling biosimilars in North Africa
Through a partnership with the Moroccan firm Sothema Labs, the Russian biotech hopes to manufacture and market its copycat biologics in the region.
By Suzanne Elvidge • Dec. 14, 2017 -
PwC: Opioids and Medicare pressures will challenge industry in 2018
BioPharma Dive Senior Editor Lisa LaMotta sat down with the US Pharma and Life Science Leader from PwC to discuss issues to watch in 2018.
By Lisa LaMotta • Dec. 12, 2017 -
Kendall Davis/BioPharma Dive
How can healthcare supply chains improve? Experts weigh in.
From supplier relations to inventory management, healthcare is seen as one of the greatest opportunities for supply chain improvement. Here's why.
By Edwin Lopez • Dec. 11, 2017 -
Wuxi preps for biologics manufacturing surge in China
The contract manufacturer recently began operations at what it says is the world's largest production facility for biologics using single-use bioreactors.
By Ned Pagliarulo • Dec. 7, 2017 -
FDA lays groundwork for regulating 3D-printed drugs
The agency says it's the first regulator in the world to provide technical guidelines for manufacturers seeking to make medical products on 3D printers.
By Jacob Bell • Dec. 7, 2017 -
Sponsored by Lee Industries
Meeting vessel fabrication challenges for Bio/Pharma applications
Proper installation and start-up of complex vessels for Bio/Pharma applications is critical to prevent installation damage and to ensure safe operation compliant with your company’s processing requirements.
Dec. 4, 2017 -
Cali to Massachusetts: We're the better biotech hub
The Golden State holds a number of advantages over its East Coast rival, including greater venture capital investments in life sciences, according to a new report.
By Jacob Bell • Dec. 1, 2017 -
Corning adds 185 jobs to support pharma packaging production
Stepped-up hiring is part of a major investment into Valor Glass, a damage-resistant type of glassware Corning developed together with Merck and Pfizer.
By Ned Pagliarulo • Nov. 30, 2017 -
Merck unveils big plans for new UK HQ
Dubbed UK Discovery Centre, the facility could support nearly 1,000 jobs, including 150 new research positions.
By Jacob Bell • Nov. 30, 2017 -
Fresenius builds out its US manufacturing presence
The German healthcare company plans to pump $100 million into an expansion of its North Carolina production site.
By Suzanne Elvidge • Nov. 30, 2017 -
Bluebird Bio doubles down on viral manufacturing
The gene therapy biotech is adding to its manufacturing capabilities as it readies plans to bring multiple new products to market in the coming years.
By Lisa LaMotta • Nov. 29, 2017 -
Sponsored by World Courier
Modern medicine: Cell and gene therapy
Transporting time- and temperature-sensitive products is a challenging responsibility for companies who need a reliable partner to ensure these life-saving therapies are delivered efficiently and successfully.
Nov. 28, 2017 -
UPS digs deeper into drug distribution
The logistics provider obtained a license to relabel drugs for pharmaceutical manufacturing clients in Georgia.
By Edwin Lopez • Nov. 28, 2017 -
FDA releases its blistering Lupin warning letter
Lupin shares slumped when the drugmaker disclosed last week that it had been cited. Now published, the letter shows the extent of Lupin's violations.
By Jacob Bell • Nov. 16, 2017 -
Recipharm to shutter two plants, cutting 225 jobs
The restructuring is part of Recipharm's efforts to boost the profitability of its solid dose manufacturing business.
By Ned Pagliarulo • Nov. 16, 2017 -
Avista doubles API manufacturing capacity at CO facility
The CDMO has expanded in Massachusetts and North Carolina as well, aiming to build out the company's operational capacity.
By Ned Pagliarulo • Nov. 16, 2017 -
Quotient Sciences buys UK CDMO in third acquisition of year
Not one week after unveiling a corporate rebranding, Quotient announced it would acquire the British CDMO Pharmaterials.
By Ned Pagliarulo • Nov. 16, 2017 -
Hospitals facing IV solution shortages after Hurricane Maria
The FDA has granted one of the largest manufacturers of IV solutions permission to import IV bags from its facilities in other countries.
By David Lim • Nov. 16, 2017 -
Courtesy of FujiFilm
Fujifilm boosts biopharma CDMO unit with $28M investment
The Japanese company has sped up the timeline for further expansion of its contract business, citing growing customer demand.
By Suzanne Elvidge • Nov. 9, 2017 -
'Hard' Brexit risks disrupting supply of thousands of drugs
A departure by the U.K. from the EU without a trade deal could imperil drug supply chains, a trade group of European drugmakers warned.
By Ned Pagliarulo • Nov. 8, 2017 -
Roche to shift packaging operations, trimming 235 jobs
Packaging of established, large-volume products will be relocated from the Kaiseragust site, freeing up capacity to focus on specialized medicines.
By Ned Pagliarulo • Nov. 8, 2017
Previous
